Article
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
19 Nov 2015
Abstract excerpt
HIV-1 provirus integration results in a persistent latently infected reservoir that is recalcitrant to combined antiretroviral therapy (cART) with lifelong treatment being the only option. The "shock and kill" strategy aims to eradicate latent HIV by reactivating proviral gene expression in the context of cART treatment. Gene-specific transcriptional activation can be achieved using the RNA-guided CRISPR-Cas9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
